7 Biotechs Fighting Rare Diseases With Gene-Editing Tech

As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases are defined as those affecting fewer than 1 in 200.000 people with almost 80% of all rare diseases being of genetic nature. With recent progress in gene-editing technologies, including breakthroughs …